SYSTEM FOR CHEMILUMINESCENCE-BASED DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
20170285026 · 2017-10-05
Assignee
Inventors
- William Tuchfarber (Amelia, OH, US)
- Douglas Harris (Cincinnati, OH, US)
- James Marous (South Vienna, OH, US)
Cpc classification
G01N2469/10
PHYSICS
B01L2200/025
PERFORMING OPERATIONS; TRANSPORTING
B01L3/50273
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0867
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/0481
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502715
PERFORMING OPERATIONS; TRANSPORTING
B01L3/5023
PERFORMING OPERATIONS; TRANSPORTING
C12Y111/01007
CHEMISTRY; METALLURGY
International classification
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
The present disclosure comprises a device and accompanying method for determining the presence or absence of Methicillin-resistant Staphylococcus aureus in a sample. The disclosure includes the following elements: (1) a lateral flow strip for microfluidic manipulation of a sample; (2) a cassette device for containing the lateral flow strip and enabling interface with a detection device; (3) a cassette handler; (4) a luminous reagent delivery device; and (5) an electromagnetic radiation detection device capable of converting chemiluminescent radiation from the lateral flow strip into an output for a user.
Claims
1. A cassette device for determining the presence or absence of Methicillin-resistant Staphylococcus aureus (“MRSA”) in a sample, comprising: (a) a lateral flow strip, comprising (1) an absorbent pad for receiving a liquid sample mixed with an enzyme conjugate, (2) a region for accepting a luminous reagent, (3) a region comprising a reaction zone, wherein the reaction zone includes a substance binding region, a negative control region and a positive control region, and (4) a microfluidic pump, and wherein (i) the sample acceptor pad, the luminous reagent accepting region, the reaction zone, and microfluidic pump are in fluid communication, and facilitate fluid flow in a downstream direction from the sample acceptor pad to the microfluidic pump; (ii) the substance binding region includes an antibody for capturing a target substance; (iii) the positive control region includes an antibody for capturing the enzyme conjugate, and (iv) the enzyme conjugate is capable of binding with the substance and reacting with the luminous reagent, thereby generating electromagnetic radiation; and (b) a housing, comprising (1) an upper component comprising a first basin for sample preparation, a second basin for sample preparation, a first well for adding a sample, a second well for adding a luminous reagent, a plurality of apertures to allow electromagnetic radiation generated on the lateral flow strip to escape the cassette device, a plurality of latch receiving regions, a plurality of pressure tabs to contact the lateral flow strip, and a plurality of alignment guides to secure the lateral flow strip in place; (2) a lower component comprising a region upon which the lateral flow strip rests, a sample reservoir, a plurality of alignment guides to secure the lateral flow strip in place, a plurality of latches located complimentary to the latch receiving regions on the upper housing and capable of exerting positive pressure to mechanically latch the upper component and the lower component together, and a plurality of detents for mechanically securing the cassette device in a cassette handler device; (3) a means for electronically identifying the cassette device; and wherein (i) the first well and second well are in fluid communication with the lateral flow strip; (ii) the first well includes a shielding structure configured to contact the lateral flow strip; (iii) the second well includes a nipple structure; and (iv) the apertures are configured to precisely direct electromagnetic radiation to a reader device.
2. The cassette device of claim 1, wherein the antibody for capturing the target substance is a Penicillin Binding Protein 2a (“PBP2a”) monoclonal antibody
3. The cassette device of claim 1, wherein the enzyme conjugate is horseradish peroxidase (“HRP”).
4. The cassette device of claim 3, wherein the antibody for capturing the HRP is an IgG antibody.
5. The cassette device of claim 1, wherein the luminous reagent is luminol.
6. The cassette device of claim 1, wherein one or more of the first through fourth regions are partially or completely overlapping.
7. A cassette handler, comprising: (1) a cassette device receiving component; (2) a plurality of spring-loaded plungers located complimentary to a plurality of detents in a cassette device; and (3) an aperture located on an upper side of the handler; and wherein (i) the plungers secure the cassette device in an aligned position so that the device is precisely aligned in relation to the aperture; (ii) the aligned position is affirmatively indicated to a device user; and (iii) the aperture is precisely aligned with certain diodes of a sensor integrated chip.
8. An electromagnetic radiation detection device, comprising: a cassette handler; a luminous reagent delivery device; an output component configured to output data regarding the sample, based upon the electromagnetic radiation detected; and a self-calibrating sensor integrated chip comprising (1) a plurality of discrete detection diodes; and (2) a plurality of calibration integrated chips; wherein (i) each diode is corrected by a calibration integrated chip that causes the plurality of diodes to produce identical electrical signals in response to a zero-photon condition; and (ii) a calibration coefficient is calculated for each diode so that an identical electrical signal is attributed to each diode when the plurality of diodes is exposed to the same number of photons per second.
9. The device of claim 8 where the luminous reagent delivery device includes a peristaltic metering pump and a delivery tube; and is configured to deliver 400 μL of luminous reagent to a cassette device at a rate of 4 μL/sec.
10. The device of claim 8 where the calibration coefficient is calculated using a first-order linear regression.
11. A method of using an electromagnetic radiation device to detect the presence or absence of a plurality of substances in a sample, comprising: (1) providing a test format which includes a sample capture signal for each substance, at least one negative control (background) signal, and at least one positive control signal; (2) providing the signals to the detector device; and (3) directing each signal to a plurality of discrete diodes.
12. A method detecting the presence or absence of Methicillin-resistant Staphylococcus aureus in a sample, comprising: providing a sample from an individual; and utilizing any one of (1) the cassette device (2) the cassette handler; or (3) the detection device to analyze the sample.
13. A method detecting the presence or absence of Methicillin-resistant Staphylococcus aureus in a sample, comprising: providing a sample of fluid from an individual; placing the sample in a specimen tube containing a growth medium; incubating the sample; adding a solution containing an extraction agent to the sample; filtering the sample solution; adding the sample solution to a neutralization solution; adding a PBP2a antibody conjugated with an enzyme conjugate to the sample solution; and placing the sample solution into the sample well of a cassette device that includes a lateral flow strip.
14. The method of claim 13 further comprising: inserting the cassette device into a cassette handling device of an electromagnetic radiation detection device; delivering a luminous reagent to a luminol well on the cassette device; detecting electromagnetic radiation escaping from the cassette device with the electromagnetic detection device; producing electrical signals in response to the detected electromagnetic radiation; calibrating and processing the electrical signals; producing output in response to the calibrated and processed electrical signals indicating one of the following: (1) an invalid test, (2) a valid test in which MRSA is absent, (3) a valid test in which MRSA is present.
15. The method of claim 13, in which the growth medium is a Trypticase soy broth.
16. The method of claim 13, in which the sample is incubated in a heat block at about 37° C. for at least 16 hours.
17. The method of claim 13, in which the extraction agent is a buffered solution of NaOH.
18. The method of claim 13, in which the neutralization agent is a buffered solution of HCl.
19. The method of claim 13, in which the sample is filtered through a 0.2 micron filter.
20. The method of claim 13, in which the enzyme conjugate is horseradish peroxidase.
21. The method of claim 13, in which the lateral flow strip includes a region for accepting a sample; a region for accepting a luminous reagent; a reaction zone; and a microfluidic pump, all of which are in fluid communication.
22. The method of claim 21, in which the reaction zone includes a sample capture region, a negative control region, and a positive control region.
23. The method of claim 22, in which the sample capture region includes a monoclonal PBP2a antibody.
24. The method of claim 22, in which the positive control region includes an anti-mouse IgG antibody.
25. The method of claim 14, in which at least 400 μL luminol is added at a rate of 4 μL/sec.
26. The method of claim 14, in which the detection device interprets a test as invalid if no electromagnetic radiation is produced from the cassette device positive control region.
27. The method of claim 14, in which the detection device interprets a test as negative for MRSA if electromagnetic radiation is produced from the cassette device positive control region, and no electromagnetic radiation is produced from the cassette device sample capture region.
28. The method of claim 14, in which the detection device interprets a test as positive for MRSA if electromagnetic radiation is produced from both the cassette device positive control region and the sample capture region.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0023] The objects and advantages of the present disclosure will be further appreciated in light of the following detailed descriptions and drawings in which:
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
DETAILED DESCRIPTION OF THE INVENTION
[0035] The detailed description of the present disclosure will be primarily be, but not entirely be, limited to subcomponents, subsystems, and sub methods of detecting Methicillin-resistant Staphylococcus aureus (“MRSA”) in a human using chemiluminescence. Therefore, although not described in detail here, other essential features which are readily interpreted from or incorporated along with the present disclosure shall be included as part of the present disclosure. The disclosed specification provides specific examples to portray inventive steps, but which will not necessarily cover all possible embodiments commonly known to those skilled in the art. For example, the specific invention will not necessarily include all obvious features needed for operation, examples being a battery or power source which is required to power electronics, or for example, a particular antenna design that allows wireless communication with a particular external information display device. The invention includes reference to PCT/US2012/053705, “System for Chemiluminescence-Based Detection,” which is included herein by reference in its entirety. The disclosed invention may benefit from chemicals, materials, sensors, electronics, microfluidics, algorithms, computing, software, systems, and other features or designs, as commonly known to those skilled in the art of electronics, diagnostics, clinical tools, computing, and product design. Many of these auxiliary features of the device may, or may not, also require aspects of the disclosed invention.
[0036] The disclosure teaches a cassette device for determining the presence or absence of MRSA in a sample. With reference to
[0037] Adjacent to the upstream end, the lateral flow strip 100 also includes a region 103 for accepting a luminous reagent, i.e. luminol. Downstream from and adjacent to the luminol accepting region 103, the lateral flow strip includes a reaction zone 104. The reaction zone comprises a capture region 105, a negative control region 106 and a positive control region 107. The capture region 105 contains a means for capturing the PBP2a. The means for capturing the MRSA PBP2a is an anti-MRSA PBP2a monoclonal antibody. The capture region's PBP2a antibody acts as a sandwich assay by binding with the PBP2a and another MRSA PBP2a antibody bound to the PBP2a (if any) in the sample fluid. When luminol is supplied to the test strip, any captured PBP2a conjugated with HRP will produce electromagnetic radiation, which the Sensor IC will interpret as indicating the presence of MRSA (assuming the test is otherwise valid). If no signal is generated from the capture region, the Sensor IC will interpret such a result as indicating the absence of MRSA in the sample, also assuming the test is otherwise valid.
[0038] The negative or blank control region 106 can be used to calibrate the test for background noise (electromagnetic radiation). The level of such background noise contribution to a positive signal read by the Sensor IC device can thereby be determined and accounted for. The positive control region 107 includes a means for trapping the HRP, and serves as a means to determine if the sample flowed down the strip. The means for trapping the HRP is an IgG antibody. The IgG antibody in the positive control region 107 acts as a sandwich assay, and binds another IgG antibody in the sample fluid that is bound to the HRP. If HRP is captured in the positive control region 107, electromagnetic radiation will be produced, which the Sensor IC device will interpret as a valid test. If a sample fails to flow to the positive control region 107, the Sensor IC will interpret the absence of a signal as an invalid test.
[0039] Downstream of the reaction zone 104, the lateral flow strip of the device disclosed herein also includes an alignment reference line 108. The alignment reference line 108 is oriented across the width of the lateral flow strip, and will appear in the reference line window 208b when the lateral flow strip is properly seated in the lower cassette housing 201d, and the upper cassette housing 201b is properly secured in place. All of the regions of the lateral flow strip described above are in fluid communication. If one or more of such regions are omitted, the remaining regions will remain in fluid communication. One or more of the regions described above may also be partially or completely overlapping.
[0040] With reference to
[0041] As depicted in
[0042] The mechanical interaction between the upper component and the lower component is accomplished by means of four snap closures. The snap closures are located on the perimeter of the 91 mm sides of the cassette housing 201, and correspond roughly to the four corners of the housing. The snap closures are comprised of clips 211d projecting upward from the lower component, and complimentary latching areas 211b on the upper component. When properly latched, the four snap closures exert positive pressure that serves to: (1) secure the cassette housing components together, and (2) press the lateral flow strip together with the sample acceptor pad and the microfluidic pump.
[0043] With reference to
[0044] With reference to
[0045] With reference to
[0046] The lower cassette housing 201d also includes four snap closure latches 211d. The snap closure latches 211d engage the complimentary latching areas (
[0047] With further reference to
[0048] As depicted in
[0049] The electromagnetic radiation generated by a MRSA assay conducted using the cassette device described herein could be detected by using any appropriately configured Sensor IC detection device, including that described herein. In addition to the cassette handler disclosed above, the Sensor IC detection device also includes a luminous reagent delivery device. With reference to
[0050] As depicted in
[0051] The disclosed detection device also includes a detection component comprising a self-calibrating Sensor IC with a discrete detection region, a charge-coupled device, an electro-optical sensor, a photodetector, a photodiode, a photomultiplier tube, a single-photon avalanche diode and a visible light photon counter. The detection device is configured to (1) detect electromagnetic radiation generated as a result of a chemical reaction occurring on a cassette device; (2) convert the electromagnetic radiation into an electrical signal; (3) process the electrical signal to determine whether MRSA is present or absent in the sample; and (4) communicate whether MRSA is present or absent in a sample after the signal is processed. The detection device may also be configured to communicate data to one or more additional devices. The components and various configurations thereof required to carry out these operations are known to those skilled in the art.
[0052] With reference to
[0053] In various embodiments, the disclosed invention also includes a method for analyzing a sample, including the following processes: providing a sample; placing the sample in at least one sample preparation basin on a cassette device; mixing the sample and applying the sample to a lateral flow strip through a sample well; inserting the cassette device into a Sensor IC device; using a luminous reagent delivery device to add luminol to a cassette device through a luminol well. The luminol migrates into the test strip reaction zone and reacts with the sample fluid, wherein the Sensor IC device detects the presence or absence of MRSA in the sample.
[0054] In the disclosed method, a sample of fluid potentially containing MRSA is taken by applying a standard cotton swab to the inside of the first 1 to 2 mm of an individual's nasal cavity and placing the sample in a specimen tube containing a growth medium, such as Trypticase soy broth. Once placed in the growth medium, the specimen tube is tightly capped and incubated for at least 16 hours, and no more than 30 hours, at 37° C. in a heat block. The disclosed method of sample treatment differs from typical hospital laboratory practice in that specimens are usually loosely capped, and hospital incubators are normally used to incubate the sample.
[0055] An extraction reagent comprised of NaOH and buffering agents is added to Basin A, and a neutralization reagent comprised of a solution of dilute HCl and buffering agents is added to Basin B. A syringe is used to take up the entire sample from the specimen tube, and a 0.2 micron filter is placed onto the syringe; the sample is then expelled through the filter into Basin A. Then the extraction reagent in Basin A is drawn through the filter into the syringe with the sample, where it breaks down any MRSA that is present. Then all of the liquid in the syringe is expelled through the filter into Basin B. This pushes any PBP2a present in the sample into Basin B. At this point, a monoclonal PBP2a antibody conjugated with HRP is added to Basin B. A pipette is then used to extract the entire contents of Basin B and place them into sample well C.
[0056] The liquid sample will flow onto the sample acceptor pad and then downstream onto the lateral flow strip. The sample will continue to flow downstream toward the reaction zone, where it will interact with the sample capture region, which is a portion of the lateral flow strip containing a monoclonal MRSA PBP2a antibody. Some of the HRP conjugated with PBP2a will bind to the PBP2a antibody in the capture region, and unbound HRP conjugated antibody will then flow downstream along the lateral flow strip to a negative control region, and will continue toward the positive control region. The positive control region is treated with IgG antibody specific for murine antibodies. Unbound HRP conjugated antibody will be captured at the positive control region. The cassette is then inserted into the cassette handler, which is located within the Sensor IC detection device. A luminous reagent delivery device then introduces luminol into the luminol channel that is located on the upper surface of the cassette device. The luminol flows down the channel to a luminol well in the cassette device, and flows through the luminol well and onto the luminol acceptance region of the lateral flow strip. The luminol flows downstream along the lateral flow strip to the reaction zone, where it reacts with the HRP trapped in the capture region and the positive control region, and produces electromagnetic radiation. The electromagnetic radiation is transmitted through a row of three apertures in the upper portion of the cassette device and positioned directly above the sample capture region, the negative control region and positive control region. The cassette handler guides the cassette into a position in which the cassette openings are aligned with electromagnetic radiation detectors of the detection device. A door prevents the entry of interfering light into the detection device. The cassette is stabilized in position by four hemispherical ball detents (located approximately at the corners of the underside of the cassette) that interact with four spring-mounted ball plungers of the cassette handler. The electromagnetic radiation produced in the sample capture region, and control regions is then detected by the radiation detection device, and electrical signals are produced in response to the detection. The electrical signals are calibrated and then processed by a processor located within the detection device. A signal is then generated indicating a valid or invalid test, and if the test is valid, the device generates a signal indicating the presence or absence of MRSA PBP2a and communicates to both the user interface screen and printer, where a message is printed and made available for use by a user.
[0057] The disclosed invention also includes a method of using a Sensor IC detection device in which a sample is analyzed by providing a test format which includes a sample capture signal, a positive control signal, and a negative control (background) signal to the detector device. Because the detector device has 25 discrete photodiodes, and a single sample tested according to the disclosed test format uses 9 diodes, the test format may potentially be expanded to include multiple analytes. Accordingly, the disclosed test format and Sensor IC device could allow accurate testing of up to 7 analytes simultaneously.
[0058] The disclosed invention also includes a method for analyzing a sample, including detecting electromagnetic radiation emitted from the cassette device using the detection device.
[0059] The method further includes detecting the presence or absence of MRSA in a sample, utilizing any of the cassette, cassette handler, or the detection device, according to the disclosed methods.
[0060] The arrangements and descriptions related above are example embodiments only, and other obvious configurations and applications are included within spirit of the disclosed invention. The disclosed invention is in no way limited to the methods and materials described. These examples serve to illustrate that although the specification herein does not list all possible device features or arrangements or methods for all possible applications, the invention is broad and may incorporate other useful methods or aspects of materials, devices, or systems or other embodiments, which are readily understood and obvious for the broad applications of the present invention.
[0061] This has been a description of the present invention along with a preferred method of practicing the present invention, however the invention itself should only be defined by the appended claims.